![Frontiers | Mast Cells in Gut and Brain and Their Potential Role as an Emerging Therapeutic Target for Neural Diseases Frontiers | Mast Cells in Gut and Brain and Their Potential Role as an Emerging Therapeutic Target for Neural Diseases](https://www.frontiersin.org/files/Articles/459391/fncel-13-00345-HTML/image_m/fncel-13-00345-g001.jpg)
Frontiers | Mast Cells in Gut and Brain and Their Potential Role as an Emerging Therapeutic Target for Neural Diseases
![IJERPH | Free Full-Text | Risk and Protective Factors in Adolescent Suicidal Behaviour: A Network Analysis IJERPH | Free Full-Text | Risk and Protective Factors in Adolescent Suicidal Behaviour: A Network Analysis](https://pub.mdpi-res.com/ijerph/ijerph-19-01784/article_deploy/html/images/ijerph-19-01784-g001.png?1644485518)
IJERPH | Free Full-Text | Risk and Protective Factors in Adolescent Suicidal Behaviour: A Network Analysis
![Cureus | First Reported Case of Reversible Cerebral Vasoconstriction Syndrome After a SARS-CoV-2 Vaccine | Article Cureus | First Reported Case of Reversible Cerebral Vasoconstriction Syndrome After a SARS-CoV-2 Vaccine | Article](https://assets.cureus.com/uploads/figure/file/284772/lightbox_8211b6e0432611ec9ca9632004965715-fig1_steinbock2.png)
Cureus | First Reported Case of Reversible Cerebral Vasoconstriction Syndrome After a SARS-CoV-2 Vaccine | Article
![Frontiers | Low rates of headache and migraine associated with intravenous immunoglobulin infusion using a 15-minute rate escalation protocol in 123 patients with primary immunodeficiency Frontiers | Low rates of headache and migraine associated with intravenous immunoglobulin infusion using a 15-minute rate escalation protocol in 123 patients with primary immunodeficiency](https://www.frontiersin.org/files/Articles/1075527/fimmu-13-1075527-HTML/image_m/fimmu-13-1075527-g001.jpg)